Clinical Trial

Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated February 26, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial is conducted in China. The aim of the trial is to investigate the efficacy and safety of an Bamboo cane polysaccharide (oral LC-Z300-01) in subjects with type 2 diabetes.
Trial Details
NCT Number NCT06847178
Lead Sponsor Shanghai Changzheng Hospital
Conditions Diabetes, Type 2 Diabetes
Enrollment 60 participants
Start Date 2025-03-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-26